Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
As a result, Imago will become a subsidiary of Merck.
Acquisition expands Merck’s growing hematology portfolio
The company has reported total income of Rs. 77.60 crores during the period ended September 30, 2022
The inspection concluded with four Form 483 observations. None of the observations were related to data integrity.
Advancing to IND-enabling studies with multiple drug candidates
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Subscribe To Our Newsletter & Stay Updated